» Articles » PMID: 30103019

High-Sensitivity Troponin T and Incident Heart Failure in Older Men: British Regional Heart Study

Overview
Journal J Card Fail
Date 2018 Aug 14
PMID 30103019
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aim of this work was to study the association of high-sensitivity troponin T (hsTnT) with incident heart failure (HF), and implications for its use in prediction models.

Methods And Results: In the British Regional Heart Study, 3852 men aged 60-79years without baseline HF (3165 without baseline chronic heart disease) were followed for a median of 12.6years, during which 295 incident cases of HF occurred (7.7%). A 1-SD increase in log-transformed hsTnT was associated with a higher risk of incident HF after adjusting for classic risk factors (hazard ratio [HR] 1.58, 95% confidence interval [CI] 1.42-1.77) and after additional adjustment for N-terminal pro-B-type natriuretic peptide (NT-proBNP; HR 1.34, 95% CI 1.19-1.52). The strength of the association between hsTnT and incident HF did not differ by strata of other risk factors. An hsTnT concentration of <5ng/L had a sensitivity of 99.7% (95% CI 98.1%-99.9%) and a specificity of 3.4% (95% CI 2.8%-4.0%). A risk-prediction model including classic risk factors and NT-proBNP yielded a C-index of 0.791, but addition of hsTnT did not further improve prediction (P = .28).

Conclusions: Elevated hsTnT is consistently associated with risk of HF in older men. HF occurred rarely over 12years when baseline hsTnT was below the limit of detection. hsTnT measurement, however, does not improve HF prediction in a model already containing NT-proBNP.

Citing Articles

Scalable Risk Stratification for Heart Failure Using Artificial Intelligence applied to 12-lead Electrocardiographic Images: A Multinational Study.

Dhingra L, Aminorroaya A, Sangha V, Pedroso Camargos A, Asselbergs F, Brant L medRxiv. 2024; .

PMID: 38633808 PMC: 11023679. DOI: 10.1101/2024.04.02.24305232.


Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis.

Shi Y, Dong G, Liu J, Shuang X, Liu C, Yang C Front Cardiovasc Med. 2022; 9:854501.

PMID: 35498052 PMC: 9046693. DOI: 10.3389/fcvm.2022.854501.


Associations of the systolic and diastolic components of orthostatic hypotension with markers of cardiovascular risk in older men: A cross-sectional analysis from The British Regional Heart Study.

Gilani A, Ramsay S, Juraschek S, Papacosta O, Lennon L, Whincup P J Clin Hypertens (Greenwich). 2020; 22(10):1892-1901.

PMID: 33231377 PMC: 8029713. DOI: 10.1111/jch.13996.


Safety of a Combined WB-EMS and High-Protein Diet Intervention in Sarcopenic Obese Elderly Men.

Kemmler W, von Stengel S, Kohl M, Rohleder N, Bertsch T, Sieber C Clin Interv Aging. 2020; 15:953-967.

PMID: 32612355 PMC: 7322975. DOI: 10.2147/CIA.S248868.


Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction.

Howlett J, Sharma N, Alemayehu W, Dyck J, Anderson T, Fine N ESC Heart Fail. 2020; 7(5):2725-2733.

PMID: 32592541 PMC: 7524210. DOI: 10.1002/ehf2.12863.


References
1.
Huynh Q, Saito M, Blizzard C, Eskandari M, Johnson B, Adabi G . Roles of nonclinical and clinical data in prediction of 30-day rehospitalization or death among heart failure patients. J Card Fail. 2015; 21(5):374-381. DOI: 10.1016/j.cardfail.2015.02.002. View

2.
Jhund P, McMurray J . Heart failure after acute myocardial infarction: a lost battle in the war on heart failure?. Circulation. 2008; 118(20):2019-21. DOI: 10.1161/CIRCULATIONAHA.108.813493. View

3.
Tanindi A, Cemri M . Troponin elevation in conditions other than acute coronary syndromes. Vasc Health Risk Manag. 2011; 7:597-603. PMC: 3212425. DOI: 10.2147/VHRM.S24509. View

4.
Ziaeian B, Fonarow G . Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016; 13(6):368-78. PMC: 4868779. DOI: 10.1038/nrcardio.2016.25. View

5.
Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special.... Eur Heart J. 2016; 37(27):2129-2200. DOI: 10.1093/eurheartj/ehw128. View